Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Bellicum Pharmaceuticals

Bellicum Pharmaceuticals

Bellicum Pharmaceuticals is a pharmaceutical and biotechnology company developing cell therapies to treat cancer, blood, and immune diseases.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

January 2014
Bellicum Pharmaceuticals raises a $34,400,000 series B round from AVG Ventures and Remeditex Ventures.
March 8, 2012
Bellicum Pharmaceuticals raises a $20,000,000 series B round from AVG Ventures and Remeditex Ventures.
November 4, 2009
Bellicum Pharmaceuticals raises a $4,500,000 series A round.
October 9, 2007
Bellicum Pharmaceuticals raises a $2,300,000 seed round.
July 1, 2003
Bellicum Pharmaceuticals was founded by David M. Spencer and Kevin Slawin.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Rapha Capital Management, LLC and Ponce Therapeutics, Inc.
February 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Ponce Therapeutics, Inc. ("Ponce"), a company leveraging the growing scientific knowledge surrounding the aging process to develop anti-aging...

References

Golden logo
By using this site, you agree to our Terms & Conditions.